[126th JSS] Presenting Our Pancreatic Cancer Study
On April 25, during the 126th Annual Congress of the Japan Surgical Society held in Sapporo, Prof. Hidenori Takahashi, a co-investigator of the PC-CURE-1 study, presented a talk titled:
“Impact of Induction FOLFIRINOX versus Gemcitabine with Nab-Paclitaxel on Early Recurrence and Post-Recurrence Survival after Conversion Surgery for Unresectable Pancreatic Cancer.”